Abiopharma

🔍 Sanders Edward Lawrence III (Director)

Company: SHORE BANCSHARES INC (SHBI)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 2,310 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 72,856.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 10,515.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By Spouse's IRA | shares_owned_after: 5,958.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 6,447.00
• Sold 2,310 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,855.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F5

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Reflects an increase in beneficial ownership resulting from an exempt acquisition of common stock under Shore Bancshares Dividend Reinvestment Plan pursuant to Rule 16a-11.
• F3: Each restricted stock unit represents a contingent right to receive one share of SHBI common stock.
• F4: These restricted stock units vested on July 29, 2026.
• F5: The restricted stock units vest as follows: 1,855 units on May 21, 2027.